RNA sequencing for AML patients. RNA sequencing for AML patients
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
We systematically evaluated osimertinib’s usage for treating AML patients from the subgroup with high level of CD34 and warrant clinical investigation in the treatment of refractory/resistant AML. Overall design: Examination of osimertinib sensitivity for AML patients with different expression levels of CD34.
创建时间：
2023-12-01
